Evidence map›Paper›PMID 20958329›Full record

ArticleAlcoholism, clinical and experimental research2011

Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption.

Panayotis K Thanos, Vanessa Gopez, Foteini Delis, Michael Michaelides, David K Grandy, Gene-Jack Wang, George Kunos, Nora D Volkow

Abstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A Single δFrontiers in pharmacology · 2019
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Chronic Δ⁹-tetrahydrocannabinol exposure induces a sensitization of dopamine D₂/₃ receptors in the mesoaccumbens and nigrostriatal systems.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Panayotis K ThanosDepartment of Health and Human Services, Laboratory of Neuroimaging, NIAAA, NIH, Bethesda, Maryland, USA. thanos@bnl.gov
Vanessa Gopez
Foteini Delis
Michael Michaelides
David K Grandy
Gene-Jack Wang
George Kunos
Nora D Volkow
Brookhaven National Laboratory · USStony Brook University · USNational Institutes of Health · USOregon Health & Science University · US

Funding

Translational Research and Science Education (OUT)P60AA007611 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Marian Lee Logrip · 2003 to 2026
$45.5M
Endocannabinoids And Energy HomeostasisZIAAA000350 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI KUNOS, GEORGE · 2009 to 2025
$28.4M
Neurobiology of Substance Abuse & Addiction - Preclinical StudiesZIAAA000551 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI VOLKOW, NORA D. · 2009 to 2013
$8.2M
RAT RESEARCH COMPONENTP50AA007611 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI LUMENG, LAWRENCE · 1987 to 2002
$5.3M
Mapping the Genes for Ethanol-Related PhenotypesR01AA011034 · NIAAA · STATE UNIVERSITY NEW YORK STONY BROOK · PI HITZEMANN, ROBERT J. · 1996 to 2014
$5.1M
BRAIN IMAGING AND ALCOHOL ABUSET32AA007574 · NIAAA · STATE UNIVERSITY NEW YORK STONY BROOK · PI SEDLER, MARK J · 1997 to 2001
$210k
Intramural NIH HHS Z99 AA999999NIAAA NIH HHS AA07574NIAAA NIH HHS AA07611NIAAA NIH HHS AA 11034NIAAA NIH HHS P50 AA007611NIAAA NIH HHS R01 AA011034NIAAA NIH HHS T32 AA007574
6 · The paper itself

Abstract

backgroundThe anatomical proximity of the cannabinoid type 1 (CNR1/CB1R) and the dopamine D2 receptors (DRD2), their ability to form CB1R-DRD2 heteromers, their opposing roles in locomotion, and their involvement in ethanol's reinforcing and addictive properties prompted us to study the levels and distribution of CB1R after chronic ethanol intake, in the presence and absence of DRD2.

methodsWe monitored the drinking patterns and locomotor activity of Drd2+/+ and Drd2-/- mice consuming either water or a 20% (v/v) ethanol solution (forced ethanol intake) for 6 months and used the selective CB1 receptor antagonist [³H]SR141716A to quantify CB1R levels in different brain regions with in vitro receptor autoradiography.

resultsWe found that the lack of DRD2 leads to a marked upregulation (approximately 2-fold increase) of CB1R in the cerebral cortex, the caudate-putamen, and the nucleus accumbens, which was reversed by chronic ethanol intake.

conclusionsThe results suggest that DRD2-mediated dopaminergic neurotransmission and chronic ethanol intake exert an inhibitory effect on cannabinoid receptor expression in cortical and striatal regions implicated in the reinforcing and addictive properties of ethanol.

Indexed as

Alcohol DrinkingAlcoholismAnimalsBody WeightCentral Nervous System DepressantsDopamineEthanolMaleMiceMice, KnockoutMotor ActivityNeostriatumNucleus AccumbensPiperidinesPyrazolesReceptor, Cannabinoid, CB1Central Nervous System DepressantsDopamineEthanolPiperidinesPyrazolesReceptor, Cannabinoid, CB1Receptors, Dopamine D2Rimonabant

Identifiers

PMID20958329
PMCPMC3004984
OpenAlexW1516932354

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.